DermTech (DMTK) Competitors

DermTech (NASDAQ:DMTK) and Psychemedics (NASDAQ:PMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, earnings, valuation, community ranking, institutional ownership, media sentiment and risk.

Which has more risk & volatility, DMTK or PMD?

DermTech has a beta of 2.53, meaning that its stock price is 153% more volatile than the S&P 500. Comparatively, Psychemedics has a beta of 0.69, meaning that its stock price is 31% less volatile than the S&P 500.

Does the MarketBeat Community favor DMTK or PMD?

Psychemedics received 96 more outperform votes than DermTech when rated by MarketBeat users. Likewise, 74.35% of users gave Psychemedics an outperform vote while only 57.50% of users gave DermTech an outperform vote.

Company	Underperform	Outperform
DermTech	Outperform Votes 46 57.50%	Underperform Votes 34 42.50%
Psychemedics	Outperform Votes 142 74.35%	Underperform Votes 49 25.65%

Does the media refer more to DMTK or PMD?

In the previous week, Psychemedics had 2 more articles in the media than DermTech. MarketBeat recorded 6 mentions for Psychemedics and 4 mentions for DermTech. Psychemedics' average media sentiment score of -0.22 beat DermTech's score of -0.23 indicating that Psychemedics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DermTech	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Psychemedics	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Is DMTK or PMD more profitable?

Psychemedics has a net margin of -20.23% compared to DermTech's net margin of -572.19%. Psychemedics' return on equity of -59.21% beat DermTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DermTech	-572.19%	-138.79%	-68.96%
Psychemedics	-20.23%	-59.21%	-32.38%

Do insiders and institutionals have more ownership in DMTK or PMD?

20.5% of DermTech shares are owned by institutional investors. Comparatively, 32.1% of Psychemedics shares are owned by institutional investors. 5.1% of DermTech shares are owned by company insiders. Comparatively, 24.0% of Psychemedics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Do analysts rate DMTK or PMD?

DermTech currently has a consensus price target of $2.38, suggesting a potential upside of 560.00%. Given DermTech's higher possible upside, equities research analysts clearly believe DermTech is more favorable than Psychemedics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DermTech	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Psychemedics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has stronger valuation and earnings, DMTK or PMD?

Psychemedics has higher revenue and earnings than DermTech. Psychemedics is trading at a lower price-to-earnings ratio than DermTech, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DermTech	$15.30M	0.82	-$100.89M	-$2.70	-0.13
Psychemedics	$22.10M	0.68	-$4.15M	-$0.77	-3.37

Summary

Psychemedics beats DermTech on 12 of the 16 factors compared between the two stocks.